{"url":"https://lda.senate.gov/api/v1/filings/2c7d6b5d-c824-4581-bd96-e65c794a4dc0/","filing_uuid":"2c7d6b5d-c824-4581-bd96-e65c794a4dc0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2023,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2c7d6b5d-c824-4581-bd96-e65c794a4dc0/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mark Roberts","dt_posted":"2023-07-12T11:46:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 New Jersey Ave NW","registrant_address_2":"Suite 450","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401103367,"url":"https://lda.senate.gov/api/v1/registrants/401103367/","house_registrant_id":null,"name":"LEAVITT PARTNERS, LLC","description":"Consulting.","address_1":"601 New Jersey Ave NW","address_2":"Suite 350","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK ROBERTS","contact_telephone":"+1 202-774-1404","dt_updated":"2026-07-07T10:50:17.833084-04:00"},"client":{"id":198724,"url":"https://lda.senate.gov/api/v1/clients/198724/","client_id":36,"name":"BAXTER HEALTHCARE","general_description":"pharmaceutical and patient safety issues","client_government_entity":false,"client_self_select":null,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-07-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pharmaceutical and patient safety issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64468,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":"CLAYTON","last_name":"ALSPACH","suffix":null,"suffix_display":null},"covered_position":"Chief Health Counsel for Chairman - House Energy and Commerce Committee (E&C); Counsel - E&C; Clerk - E&C; Paid Intern - E&C","new":false},{"lobbyist":{"id":69926,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant - House; Legislative Assistant - Senate; Special Assistant to the DAS for Legislation - HHS; Planning and Policy Coordinator - HHS; Deputy Assistant Secretary - HHS; Director of the Office of Congressional Liaison - HHS","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}